HotCopper

Civmec has taken its order book to a new height of $1.5 billion. Civmec (ASX: CVL) has closed out FY26 with higher revenue, stronger margins and a substantial pipeline of contracted work, giving the engineering and construction group a solid base heading into the new financial year. Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

The NGT245 E and NGT245 D wells have both produced gas flows at the Nooitgedacht project in South Africa. Gas detected in NGT245D well ahead of cementing Production casing successfully run and cemented in NGT245 E and NGT245 D Geophysical logging completed Both wells waiting for reservoir pressure to normalise ahead of future testing Helium explorer D3 Energy (ASX: D3E) has identified gas in the NGT245D well at its Nooitgedacht project, within the ER315 permit in the Free State, South Africa.

Senetas (ASX: SEN) has delivered a year of revenue growth and a sharp improvement in cash generation, while pointing to a strong sales pipeline heading into FY2027. The network encryption specialist reported revenue of $20.2 million for the year ended June 30, up 4.7% from $19.3 million a year earlier. Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

Strong client response to Felix has driven IVF Envimed to place an additional 100-unit order.

Barge with over 40 containers and numerous other oversized loads being loaded in Seattle.

Hello and welcome to HotCopper Highlights to wrap up Week 35. It’s been another busy week on HotCopper, with AI, gold, lithium and biotech stocks dominating the boards. Let’s take a look at the stocks that had investors talking. Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

XV Lung Ventilation Analysis Software. Source: 4DMedical 4DMedical (ASX: 4DX) has capped FY26 with strong growth in scan volumes and customer sites as its CT:VQ lung imaging technology moved from regulatory approval into commercial deployment across multiple markets. Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

Imricor is a pioneer and world leader in developing MR-compatible products for interventional MR (iMR) procedures. Global collaboration advances MR-guided cardiac interventions Integrated, purpose-built solution Supports adoption of iMR-guided cardiac care Scalable commercial platform Imricor Medical Systems (ASX: IMR) has launched a new Interventional MR (iMR) lab solution in collaboration with Dutch multinational health technology company Royal Philips.

Patrys says delirium remains a significant unmet medical need.

Diamond rig drilling at the Three Saints IOCG project in Chile.